(Q37797994)

English

Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy

scientific article published on August 1, 2010

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923040%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 February 2020

title

Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923040%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1 reference

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20923040

retrieved

28 July 2024

author name string

Amanda J. Redig

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20923040

retrieved

28 July 2024

Hidayatullah G. Munshi

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20923040

retrieved

28 July 2024

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

20923040

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20923040

retrieved

28 July 2024

publication date

1 August 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923040%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923040%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 February 2020

volume

24

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923040%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 February 2020

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923040%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 February 2020

page(s)

839-844

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923040%20AND%20SRC:MED&resulttype=core&format=json

retrieved

15 February 2020

Identifiers

PubMed publication ID

20923040

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20923040

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20923040%20AND%20SRC:MED&resulttype=core&format=json

(Q37797994)

Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)